Last reviewed · How we verify

NCT06283147

Risk Assessment and Management Program (RAMP) on Knee Osteoarthritis in Primary Care

Active, enrolled NA Last updated 26 June 2025
What this trial tests

NA trial testing Risk assessment and Management Programme - Knee Osteoarthritis in Knee Osteoarthritis in 228 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
8 April 2024
Primary endpoint
30 November 2025
1 April 2026

Quick facts

Lead sponsorChinese University of Hong Kong
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposehealth services research
Enrollment228
Start date8 April 2024
Primary completion30 November 2025
Estimated completion1 April 2026
Sites1 location across Hong Kong

Drugs / interventions tested

Conditions studied

Sponsor

Chinese University of Hong Kong

Who can join

45 and older, any sex, with Knee Osteoarthritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to determine the clinical effectiveness of a Chronic Care Model (CCM) named Risk Assessment and Management Program on Knee OA (RAMP-Knee OA) in adults with knee Osteoarthritis (Knee OA) at 52 weeks. Participants will be screened for eligibility to participate. After confirming eligibility, participants will complete the baseline assessment and be randomized into one of the following groups (n=114 for each group): 1. RAMP Knee-OA group 2. Usual care group Outcomes will be measured at baseline, week 16, week 32, and week 52.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Risk Assessment and Management Program (RAMP) on knee osteoarthritis in primary care-a one-year pragmatic randomized controlled trial.
    Sit RW, Yip BH, Choi SY, Wong MC, et al · · 2026 · PMID 41629997 · DOI 10.1186/s13063-026-09469-x

Verify or expand the search:

Other recruiting trials for Knee Osteoarthritis

Currently open trials in the same condition.

Other Chinese University of Hong Kong trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06283147.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing